Abstract:Host defense antimicrobial peptides (AMPs) are recognized candidates to develop a new generation of peptide antibiotics. While high hydrophobicity can be deployed in peptides for eliminating Gram-positive bacteria, high cationicity is usually observed in AMPs against Gram-negative pathogen. This study investigates how the sequence distribution of basic amino acids affects peptide activity. For this purpose, we utilized human cathelicidin LL-37 as a template and designed four highly selective ultrashort peptides with similar length, net charge, and hydrophobic content. LL-10 + , RK-9 + , KR-8 + , and RIK-10 + showed similar activity against methicillin-resistant Staphylococcus aureus in vitro and comparable antibiofilm efficacy in a murine wound model. However, these peptides showed clear activity differences against Gram-negative pathogens with RIK-10 + (i.e., LL-37mini2) being the strongest and LL-10 + the weakest. To understand this activity difference, we characterized peptide toxicity; the effects of salts, pH, and serum on peptide activity; and the mechanism of action and determined the membrane-bound helical structure for RIK-10 + by two-dimensional NMR spectroscopy. By writing an R program, we generated charge density plots for these peptides and uncovered the importance of the N-terminal high-density basic charges for antimicrobial potency To validate this finding, we reversed the sequences of two peptides. Interestingly, sequence reversal weakened the activity of RIK-10 + but increased the activity of LL-10 + especially against Escherichia coli , Pseudomonas aeruginosa , and Acinetobacter baumannii . Those more active peptides with high cationicity at the N-terminus are also more hydrophobic based on HPLC retention times. A database search found numerous natural sequences that arrange basic amino acids primarily at the N-terminus. Combined, this study not only obtained novel peptide leads but also discovered one useful strategy for designing novel antimicrobials to control drug-resistant Gram-negative pathogens.

Design of a amphipathic and α-helical antimicrobial peptide with Val and Lys residues

Rational Design of Alpha-Helical Antimicrobial Peptide with Val and Arg Residues.

Rational Design of A-Helical Antimicrobial Peptide with Leu and Lys Residues

De Novo Design of a Leu-Arg-rich Antimicrobial Peptide

Design and Biological Activity of Beta-Hairpin-like Antimicrobial Peptide.

Design and Synthesis of a Novel Cationic Peptide with Potent and Broad-Spectrum Antimicrobial Activity

Characterization of antimicrobial activity and mechanisms of low amphipathic peptides with different α-helical propensity.

The Trp-rich Antimicrobial Amphiphiles with Intramolecular Aromatic Interactions for the Treatment of Bacterial Infection

Novel Design of Short Antimicrobial Peptides Derived from the Bactericidal Domain of Avian Β-Defensin-4.

Cell Selectivity and Interaction with Model Membranes of Val/Arg-Rich Peptides

Design of an α-helical antimicrobial peptide with improved cell-selective and potent anti-biofilm activity

Strand Length-Dependent Antimicrobial Activity And Membrane-Active Mechanism Of Arginine- And Valine-Rich Beta-Hairpin-Like Antimicrobial Peptides

Design of Novel Amphipathic α-Helical Antimicrobial Peptides with No Toxicity as Therapeutics against the Antibiotic-Resistant Gram-Negative Bacterial Pathogen, Acinetobacter Baumannii

High Specific Selectivity and Membrane-Active Mechanism of the Synthetic Centrosymmetric Α-Helical Peptides with Gly-Gly Pairs

Design Of Imperfectly Amphipathic Alpha-Helical Antimicrobial Peptides With Enhanced Cell Selectivity

Central Β-Turn Increases the Cell Selectivity of Imperfectly Amphipathic Α-Helical Peptides

Segment-Based Peptide Design Reveals the Importance of N-Terminal High Cationicity for Antimicrobial Activity Against Gram-Negative Pathogens

Design Of Embedded-Hybrid Antimicrobial Peptides With Enhanced Cell Selectivity And Anti-Biofilm Activity

Rational Design of Mirror-Like Peptides with Alanine Regulation

High Specific Selectivity and Membrane-Active Mechanism of Synthetic Cationic Hybrid Antimicrobial Peptides Based on the Peptide FV7

[Molecular design and biological activity analysis of antimicrobial peptide RIKL]